These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 2012088
1. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Espinoza LR, Jara LJ, Silveira LH, Martínez-Osuna P, Zwolinska JB, Kneer C, Aguilar JL. Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088 [Abstract] [Full Text] [Related]
2. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. Chakravarty K, Pountain G, Merry P, Byron M, Hazleman B, Scott DG. J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347 [Abstract] [Full Text] [Related]
3. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis. Meyer O, Nicaise P, Moreau S, de Bandt M, Palazzo E, Hayem G, Chazerain P, Labarre C, Kahn MF. Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442 [Abstract] [Full Text] [Related]
4. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. González-Gay MA, García-Porrúa C, Vázquez-Caruncho M. J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456 [Abstract] [Full Text] [Related]
5. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica. Berthelot JM, Lamour A, Mottier D, Pennec YL, Dueymes M, Jouquan J, Le Goff P, Youinou P. Ann Med Interne (Paris); 1992 Sep; 143(7):429-32. PubMed ID: 1300861 [Abstract] [Full Text] [Related]
6. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review. Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V. Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026 [Abstract] [Full Text] [Related]
7. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Duhaut P, Bosshard S, Calvet A, Pinede L, Demolombe-Rague S, Dumontet C, Loire R, Seydoux D, Ninet J, Pasquier J, Aymard M. J Rheumatol; 1999 Feb; 26(2):361-9. PubMed ID: 9972970 [Abstract] [Full Text] [Related]
8. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy. Martinez-Taboada VM, Bartolome MJ, Fernandez-Gonzalez MD, Blanco R, Rodriguez-Valverde V, Lopez-Hoyos M. Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520 [Abstract] [Full Text] [Related]
9. Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Duhaut P, Berruyer M, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Dechavanne M, Ninet J, Pasquier J. Arthritis Rheum; 1998 Apr; 41(4):701-9. PubMed ID: 9550480 [Abstract] [Full Text] [Related]
10. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Mattey DL, Hajeer AH, Dababneh A, Thomson W, González-Gay MA, García-Porrúa C, Ollier WE. Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865 [Abstract] [Full Text] [Related]
11. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, Farnetti E, Brini M, Portioli I. J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290 [Abstract] [Full Text] [Related]
12. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W. J Rheumatol; 1998 Nov; 25(11):2140-5. PubMed ID: 9818656 [Abstract] [Full Text] [Related]
13. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica. Baerlecken NT, Linnemann A, Gross WL, Moosig F, Vazquez-Rodriguez TR, Gonzalez-Gay MA, Martin J, Kötter I, Henes JC, Melchers I, Vaith P, Schmidt RE, Witte T. Ann Rheum Dis; 2012 Jun; 71(6):943-7. PubMed ID: 22228484 [Abstract] [Full Text] [Related]
15. Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Manna R, Latteri M, Cristiano G, Todaro L, Scuderi F, Gasbarrini G. Br J Rheumatol; 1998 Feb; 37(2):208-10. PubMed ID: 9569078 [Abstract] [Full Text] [Related]
18. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica. Braun N, Fritz P, Rieth A, Schroth W, Kimmel M, Biegger D, Zakim D, Alscher MD. J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157 [Abstract] [Full Text] [Related]
19. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population. Combe B, Sany J, Le Quellec A, Clot J, Eliaou JF. J Rheumatol; 1998 Jan; 25(1):94-8. PubMed ID: 9458210 [Abstract] [Full Text] [Related]
20. Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica. Große K, Schmidt RE, Witte T, Baerlecken NT. Scand J Rheumatol; 2013 Jan; 42(3):215-9. PubMed ID: 23682607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]